- Drug Manufacturers - General
- Healthcare
AbbVie Inc.
ABBV · US ·
NYSE
190.4
USD
+2.89
(1.52%)
-
3.02
EPS
-
63.02
P/E
-
336B
MARKET CAP
-
3.22%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 3.2 | 11 | 10.3 | 11.4 | 15.8 | 17.4 | 40.29% |
| Avg. Estimate | 3 | 10.8 | 7.03 | 8.37 | 14.8 | 16.3 | 40.29% |
| Low Estimate | 2.91 | 10.7 | 3.49 | 4.21 | 14.4 | 15.8 | 40.29% |
| No. Of Analysts | 15 | 17 | 15 | 10 | 4 | 5 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 55.3B | 64.1B | 59.2B | 66B | 70.3B | 75B | 6.27% |
| Avg. Estimate | 55B | 55.6B | 58.6B | 62.7B | 66.8B | 71.2B | 5.30% |
| Low Estimate | 54.9B | 54B | 57.6B | 61.4B | 65.4B | 69.7B | 4.90% |
| No. Of Analysts | 19 | 14 | 18 | 24 | 14 | 11 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 6.36B | 19.6B | 18.2B | 20.2B | 28.1B | 30.9B | 37.16% |
| Avg. Estimate | 5.3B | 19.2B | 11.2B | 13.8B | 26.3B | 28.9B | 40.38% |
| Low Estimate | 4.24B | 18.9B | 6.19B | 7.46B | 25.5B | 28.1B | 45.97% |
| No. Of Analysts | 19 | 14 | 18 | 24 | 14 | 11 |